Shuttle Pharma shareholders authorize reverse split up to 1-for-150 at board discretion

Filed May 27, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

• high

  Board granted authority to execute one or more reverse stock splits at cumulative ratios between 1-for-2 and 1-for-150, with timing and ratio at management's discretion (90.5% approval, 55.1% of shares outstanding).

  Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
• medium

  Say-on-pay vote passed with 95.0% support (2,650,932 For, 39,906 Against, 101,870 Abstentions), representing 47.8% of the 5,546,309 shares outstanding.

  Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
• medium

  Four directors elected with support ranging from 93.9% to 95.4% of votes cast: Christopher Cooper (2,621,457 For), Adam Chambers (2,616,680 For), George Scorsis (2,664,628 For), and Angel Liriano (2,664,666 For), with 582,364 broker non-votes on each.

  Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →